Home › Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin...
 

Keywords :   


Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin...

2013-04-17 10:47:14| Chemicals - Topix.net

Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care ... (more)

Tags: iii trial phase bayer

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
09.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
08.11Statement from the U.S. Green Building Council on the 2024 Election Results
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
Chemicals »
17.11 290 1995 ()
17.11CD Target in Sigit
17.11BBM 2022
17.11Bewet 2
17.11 VS
17.11
17.11 190F 2
17.11
More »